Product
PNEUMOVAX™23
3 clinical trials
2 indications
Indication
Pneumococcal InfectionIndication
Pneumococcal InfectionsClinical trial
A Phase 1, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Polyvalent Pneumococcal Conjugate Vaccine in Healthy Japanese Adults.Status: Completed, Estimated PCD: 2021-04-06
Clinical trial
A Phase 3, Randomized, Double-blind, Active Comparator-controlled, Multicenter Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Recipients of Allogeneic Hematopoietic Stem Cell Transplant (PNEU-STEM)Status: Completed, Estimated PCD: 2021-11-04
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by Administration of PNEUMOVAX™23 Eight Weeks Later in Children Infected With Human Immunodeficiency Virus (HIV) (PNEU-WAY PED)Status: Completed, Estimated PCD: 2021-05-03